Skip to content
sellWeak cluster of 210b5-1 plan

Martine A Rothblatt sold $5.2M of UTHR

Chairperson & CEO at UNITED THERAPEUTICS Corp. 9,500 shares at an average of $549.37, traded Oct 2, 2026, filed Oct 5, 2026.

Warning score
23
Value
$5.2M
9,500 shares
Holdings after
324,443
-3% from before
From 52-week low
+30%
low $415.34, close $541.70
From 52-week high
-9%
high $596.76, as of Oct 2, 2026

Score components

  • Role
    CEO
    +25
  • Trade size
    $5.2M at market
    +25
  • Share of holdings sold
    Sold 2.8% of holdings
    0
  • Cluster
    2 insiders selling within 14 days
    +8
  • Exercise and sell
    Shares came from an option exercise in the same filing
    -15
  • 10b5-1 plan
    Pre-scheduled under a 10b5-1 plan
    -20

What happened after comparable sells

Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.

Price around the trade, and since

From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.

UTHROct 9, 2026 · close 549.16
Since filing Oct 5, 2026: +2.4%SPY +0.5% · excess +1.9%

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™

Rows in this filing

Every transaction in Form 4 0001106578-26-000156, as filed. Open on EDGAR

DateTransactionSharesPriceValueHoldings afterFiled
Oct 2, 2026MOption exercise
Common Stockindirect: by Trust10b5-1
+9,500$117.76$1.1M333,9436 d ago
Oct 2, 2026SOpen-market sale
Common Stockindirect: by Trust10b5-1
-700$542.06$379k333,2436 d ago
Oct 2, 2026SOpen-market sale
Common Stockindirect: by Trust10b5-1
-408$542.87$221k332,8356 d ago
Oct 2, 2026SOpen-market sale
Common Stockindirect: by Trust10b5-1
-1,032$544.17$562k331,8036 d ago
Oct 2, 2026SOpen-market sale
Common Stockindirect: by Trust10b5-1
-1,280$544.90$697k330,5236 d ago
Oct 2, 2026SOpen-market sale
Common Stockindirect: by Trust10b5-1
-309$546.75$169k330,2146 d ago
Oct 2, 2026SOpen-market sale
Common Stockindirect: by Trust10b5-1
-1,171$547.99$642k329,0436 d ago
Oct 2, 2026SOpen-market sale
Common Stockindirect: by Trust10b5-1
-1,206$548.87$662k327,8376 d ago
Oct 2, 2026SOpen-market sale
Common Stockindirect: by Trust10b5-1
-757$549.59$416k327,0806 d ago
Oct 2, 2026SOpen-market sale
Common Stockindirect: by Trust10b5-1
-432$550.99$238k326,6486 d ago
Oct 2, 2026SOpen-market sale
Common Stockindirect: by Trust10b5-1
-725$551.82$400k325,9236 d ago
Oct 2, 2026SOpen-market sale
Common Stockindirect: by Trust10b5-1
-160$552.86$88k325,7636 d ago
Oct 2, 2026SOpen-market sale
Common Stockindirect: by Trust10b5-1
-80$554.30$44k325,6836 d ago
Oct 2, 2026SOpen-market sale
Common Stockindirect: by Trust10b5-1
-80$555.60$44k325,6036 d ago
Oct 2, 2026SOpen-market sale
Common Stockindirect: by Trust10b5-1
-240$557.43$134k325,3636 d ago
Oct 2, 2026SOpen-market sale
Common Stockindirect: by Trust10b5-1
-120$558.60$67k325,2436 d ago
Oct 2, 2026SOpen-market sale
Common Stockindirect: by Trust10b5-1
-120$560.66$67k325,1236 d ago
Oct 2, 2026SOpen-market sale
Common Stockindirect: by Trust10b5-1
-40$562.35$22k325,0836 d ago
Oct 2, 2026SOpen-market sale
Common Stockindirect: by Trust10b5-1
-80$563.88$45k325,0036 d ago
Oct 2, 2026SOpen-market sale
Common Stockindirect: by Trust10b5-1
-80$566.58$45k324,9236 d ago
Oct 2, 2026SOpen-market sale
Common Stockindirect: by Trust10b5-1
-240$569.90$137k324,6836 d ago
Oct 2, 2026SOpen-market sale
Common Stockindirect: by Trust10b5-1
-120$570.70$68k324,5636 d ago
Oct 2, 2026SOpen-market sale
Common Stockindirect: by Trust10b5-1
-80$572.44$46k324,4836 d ago
Oct 2, 2026SOpen-market sale
Common Stockindirect: by Trust10b5-1
-40$574.23$23k324,4436 d ago
Oct 2, 2026MOption exercise
Stock Optionderivativeindirect: by Trust10b5-1
-9,500$0.00$0309,4106 d ago

Related signals

Other insiders at UNITED THERAPEUTICS Corp and this insider’s other filings.

ScoreCompanyInsiderValueHoldingsFiled
23Weak
UTHRsell 210b5-1
UNITED THERAPEUTICS Corp
Martine A Rothblatt
Chairperson & CEO
$5.1M
9,500 shares
-3%
23Weak
UTHRsell 210b5-1
UNITED THERAPEUTICS Corp
Martine A Rothblatt
Chairperson & CEO
$5.2M
9,500 shares
-3%
23Weak
UTHRsell 210b5-1
UNITED THERAPEUTICS Corp
Martine A Rothblatt
Chairperson & CEO
$5.1M
9,500 shares
-3%
23Weak
UTHRsell 210b5-1
UNITED THERAPEUTICS Corp
Martine A Rothblatt
Chairperson & CEO
$5.1M
9,500 shares
-3%
23Weak
UTHRsell 210b5-1
UNITED THERAPEUTICS Corp
Martine A Rothblatt
Chairperson & CEO
$5.5M
9,500 shares
-3%
18Weak
UTHRsell 210b5-1
UNITED THERAPEUTICS Corp
Paul A Mahon
EVP & GENERAL COUNSEL
$4.7M
8,300 shares
-16%
23Weak
UTHRsell 210b5-1
UNITED THERAPEUTICS Corp
Martine A Rothblatt
Chairperson & CEO
$3.9M
7,580 shares
-2%
38Weak
UTHRsell 210b5-1
UNITED THERAPEUTICS Corp
Martine A Rothblatt
Chairperson & CEO
$1.1M
1,920 shares
-1%
23Weak
UTHRsell 210b5-1
UNITED THERAPEUTICS Corp
Martine A Rothblatt
Chairperson & CEO
$4.5M
9,500 shares
-3%
30Weak
UTHRsell 310b5-1
UNITED THERAPEUTICS Corp
Martine A Rothblatt
Chairperson & CEO
$4.6M
9,500 shares
-3%

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Martine A Rothblatt sold $5.2M of UTHR | InsiderTell